← Back to all trials
Recruiting
NCT01719055
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Conditions: Pain
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 4800
Sponsor: Boston Scientific Corporation
Location: Physicians Research Group, LLC Phoenix Arizona
Summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use
\- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Eligibility Criteria
Key Inclusion Criteria:
* Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
* Signed a valid, IRB/EC-approved informed consent form
* 18 years of age or older
Key Exclusion Criteria:
* Contraindicated for Boston Scientific neurostimulation system
* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Source: ClinicalTrials.gov (NCT01719055). StuddyBuddy aggregates publicly available trial information.
